Skip to content

EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02170883
Enrollment
271
Registered
2014-06-23
Start date
2015-05-31
Completion date
2019-03-31
Last updated
2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, mHealth, cluster randomized controlled trial, pharmacy practice, pharmacist

Brief summary

Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.

Interventions

OTHERInteractive SMS
OTHERUsual care

Sponsors

WelTel
CollaboratorUNKNOWN
College of Pharmacists of British Columbia
CollaboratorUNKNOWN
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma * possessing a cell-phone with ability to send/receive text messages * residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months * registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months * designated pharmacy being the main drugstore for patient * not participating in another interventional study * consent to participate in the study.

Exclusion criteria

* Unable to communicate in English * Under 14 years of age

Design outcomes

Primary

MeasureTime frameDescription
Adherence to inhaled corticosteroid medication12 monthsAdherence assessed by medication possession ratio

Secondary

MeasureTime frameDescription
Use of reliever medication for acute asthma attacks12 monthsUse of reliever medication for acute asthma attacks
Asthma controlBaselineAsthma control assessed by the Asthma Control Test
Quality of life measured by the Asthma Quality of Life QuestionnaireBaselineQuality of life measured by the Asthma Quality of Life Questionnaire
Health care resource utilization12 monthsAsthma-related hospital admissions and emergency department visits

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026